Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Gains from Sales and Divestitures (2019 - 2021)

IDEAYA Biosciences' Gains from Sales and Divestitures history spans 2 years, with the latest figure at $7312.0 for Q4 2021.

  • For Q4 2021, Gains from Sales and Divestitures changed N/A year-over-year to $7312.0; the TTM value through Dec 2021 reached $7312.0, changed N/A, while the annual FY2021 figure was $7312.0, N/A changed from the prior year.
  • Gains from Sales and Divestitures for Q4 2021 was $7312.0 at IDEAYA Biosciences, roughly flat from $7312.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $7312.0 in Q1 2021 and bottomed at $4099.0 in Q2 2019.